Yanai S, Sugiyama Y, Iga T, Fuwa T, Hanano M
Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.
Am J Physiol. 1990 Apr;258(4 Pt 1):C593-8. doi: 10.1152/ajpcell.1990.258.4.C593.
We previously clarified the specific binding sites for epidermal growth factor (EGF) in several organs in rats based on in vivo kinetic analysis (D. C. Kim, Y. Sugiyama, H. Sato, T. Fuwa, T. Iga, and M. Hanano. J. Pharm. Sci. 77: 200-207, 1988). In the present study, we have determined the extent of the receptor downregulation and the recovery rate of the available receptors for EGF in several organs in vivo. At the specified times (30 min-24 h) after intravenous administration of excess unlabeled EGF (300 micrograms/kg), the early-phase (less than 3 min) uptake clearances (k1) of the tracer amount of 125I-EGF, which are proportional to the cell-surface available receptor densities, were determined in the liver, kidney, duodenum, jejunum, ileum, stomach, and spleen. As the result, the k1 value in each organ at 30 min after intravenous administration of unlabeled EGF was lowered close to the receptor-independent clearance value, indicating that the cell-surface receptors were almost completely downregulated, and thereafter, the k1 value showed gradual recovery to the control level. Furthermore, the recovery half-lives showed interorgan differences, namely the half-life (20 min) in the liver was much shorter than those (2-4.5 h) in other organs. These results were considered to reflect the processes of the recycling of internalized EGF receptors to the cell-surface or recruitment of new receptors. It was concluded that the recovery rate of the downregulated receptors in the liver, which is most responsible for the plasma clearance of EGF, is much faster than those in other organs.
我们之前基于体内动力学分析明确了大鼠多个器官中表皮生长因子(EGF)的特异性结合位点(D.C. Kim、Y. Sugiyama、H. Sato、T. Fuwa、T. Iga和M. Hanano。《药物科学杂志》77: 200 - 207, 1988)。在本研究中,我们测定了体内多个器官中EGF受体下调的程度以及可用受体的恢复率。在静脉注射过量未标记EGF(300微克/千克)后的特定时间(30分钟 - 24小时),测定肝脏、肾脏、十二指肠、空肠、回肠、胃和脾脏中微量125I - EGF的早期阶段(小于3分钟)摄取清除率(k1),其与细胞表面可用受体密度成正比。结果,静脉注射未标记EGF后30分钟时各器官的k1值降低至接近非受体依赖性清除率值,表明细胞表面受体几乎完全下调,此后,k1值逐渐恢复至对照水平。此外,恢复半衰期存在器官间差异,即肝脏中的半衰期(20分钟)远短于其他器官中的半衰期(2 - 4.5小时)。这些结果被认为反映了内化的EGF受体循环至细胞表面或新受体招募的过程。得出的结论是,对EGF血浆清除起主要作用的肝脏中下调受体的恢复率比其他器官中的恢复率快得多。